Westfield Capital Management Co. LP Has $32.49 Million Stake in Astera Labs, Inc. $ALAB

Westfield Capital Management Co. LP raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 1.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 195,294 shares of the company’s stock after acquiring an additional 2,680 shares during the quarter. Westfield Capital Management Co. LP’s holdings in Astera Labs were worth $32,489,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Assetmark Inc. lifted its holdings in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Hilltop National Bank grew its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs during the 4th quarter worth about $33,000. National Bank of Canada FI increased its position in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after purchasing an additional 124 shares in the last quarter. Finally, Wexford Capital LP bought a new position in Astera Labs during the 3rd quarter valued at about $39,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,311,256 shares of company stock valued at $477,341,446 over the last 90 days. 10.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ALAB shares. UBS Group assumed coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Needham & Company LLC lifted their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Barclays boosted their target price on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Roth Mkm restated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Trading Down 11.4%

ALAB opened at $317.06 on Friday. The stock has a market capitalization of $54.35 billion, a PE ratio of 214.23, a PEG ratio of 4.74 and a beta of 3.95. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $372.37. The firm has a 50-day moving average price of $212.95 and a two-hundred day moving average price of $171.60.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the prior year, the firm earned $0.33 earnings per share. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.